AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-136 Cr | ₹17 Cr | ₹92 Cr | ₹-81 Cr | ₹-215 Cr |
What is the latest Cash Flow from Financing Activities ratio of AARTI DRUGS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-136 Cr |
Mar2023 | ₹17 Cr |
Mar2022 | ₹92 Cr |
Mar2021 | ₹-81 Cr |
Mar2020 | ₹-215 Cr |
How is Cash Flow from Financing Activities of AARTI DRUGS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-136 Cr | Negative | |
Mar2023 | ₹17 Cr | -82.02 | |
Mar2022 | ₹92 Cr | Positive | |
Mar2021 | ₹-81 Cr | Negative | |
Mar2020 | ₹-215 Cr | - |
Compare Cash Flow from Financing Activities of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹3,184.1 Cr | -3.7% | 1.9% | -29.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹439,126.0 Cr | 0.9% | 2.2% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,568.0 Cr | 3.3% | 4.7% | 58% | Stock Analytics | |
CIPLA | ₹125,156.0 Cr | 0.5% | 2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,176.0 Cr | -0.4% | 2.8% | 24.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,716.1 Cr | -0.8% | -0.4% | 0.8% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -3.7% |
1.9% |
-29.9% |
SENSEX | 0.2% |
2.9% |
8.7% |
You may also like the below Video Courses